Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$71.2M
-91.8% from 2023
Prescriptions
268K
$265.48 per claim
Patients
110K
77,669 prescribers
Total spending, 2024
$71.2M
$649.91 per patient
Medicare prescription drug plans paid $71.2M for Advair Diskus in 2024, for 268,126 prescriptions and refills to 109,528 patients (down 91.8% from 2023). The average cost per claim was $265.48.
California had the highest Medicare cost for Advair Diskus in 2024: $7.2M for 27,174 claims, followed by New York ($5.6M).
Thomas K Chan, pulmonary disease in New York, NY, had the highest Medicare cost for Advair Diskus in 2024: 228 claims costing $53K.
Advair Diskus is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Thomas K Chan New York, NY | Pulmonary Disease | 228 | 46 | $53K |
| Irina Zolotarevskaya Rego Park, NY | Pulmonary Disease | 238 | 45 | $48K |
| Jorge Sanchez-Masiques |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 185,940 | 1,628,430 | 417,613 | $947.1M |
| 2023 | 181,958 | 1,510,056 | 397,344 | $868.4M |
| 2024 | 77,669 | 268,126 | 109,528 | $71.2M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 214 |
| 89 |
| $46K |
| Naum Meyerovich Rego Park, NY | Internal Medicine | 135 | 31 | $26K |
| Huan A Le San Diego, CA | Pulmonary Disease | 110 | 36 | $24K |
| Oksana Levitansky Brooklyn, NY | Internal Medicine | 118 | 20 | $22K |
| Anna Gorelik Brooklyn, NY | Physician Assistant | 102 | 27 | $21K |
| Reuven Moshenyat Brooklyn, NY | Pulmonary Disease | 92 | 35 | $21K |
| Andres A Redondo Miami, FL | Pulmonary Disease | 113 | 47 | $20K |
| Julie H Yoo Fullerton, CA | Pulmonary Disease | 41 | Under 11 | $19K |
| Paulette Ong Davenport, IA | Physician Assistant | 81 | 14 | $19K |
| Jahaira L Serrano Dominguez Arecibo, PR | Pulmonary Disease | 78 | 51 | $19K |
| Yanina Rubinshteyn Rego Park, NY | Family Practice | 97 | 21 | $19K |
| Muhammad T Akbar Milwaukee, WI | Pulmonary Disease | 66 | 11 | $18K |
| Hazen H Tuck Jr. Janesville, WI | Pulmonary Disease | 51 | 17 | $18K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 54 | 18 | $18K |
| Faustinus C Onyirimba Vernon, CT | Pulmonary Disease | 53 | Under 11 | $18K |
| Richard N Read Manchester, NH | Pulmonary Disease | 30 | Under 11 | $17K |
| Robert M Tanaka Modesto, CA | Pulmonary Disease | 62 | 11 | $16K |
| Boris Sagalovich Brooklyn, NY | Pulmonary Disease | 81 | 26 | $15K |
| Amy Foster Tulsa, OK | Registered Nurse | 83 | 11 | $15K |
| Brett Brown Worcester, MA | Physician Assistant | 47 | 11 | $15K |
| Jitendrakumar S Gupta Sioux City, IA | Pulmonary Disease | 55 | 16 | $15K |
| Mark L Davis Shawnee, OK | Physician Assistant | 47 | 20 | $15K |
| Sarah F Landrum Chehalis, WA | Family Practice | 53 | 14 | $15K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 268,262 | $71.2M |